FDA approves Interscope’s EndoRotor for pulmonary indications
The US Food and Drug Admisitartion (FDA) has granted approval for the EndoRotor system of Interscope to be used in pulmonary indications. The approval enables the use of
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XThe US Food and Drug Admisitartion (FDA) has granted approval for the EndoRotor system of Interscope to be used in pulmonary indications. The approval enables the use of
Irish medical technology company Medtronic has secured approval from the US Food and Drug Administration (FDA) for its Stealth Autoguide system, which is designed to be used in
The nation’s largest commercial insurance company, UnitedHealthcare, now provides coverage for eligible patients treated with endobronchial valves for bronchoscopic lung volume reduction (BLVR). Serving nearly 50 million medical members worldwidei, UnitedHealthcare
IZI Medical Products (IZI), a leading interventional radiology medical device company and portfolio company of Shore Capital Partners, is pleased to announce it has acquired RadioMed, the manufacturer
Medical device company Conventus Orthopaedics has purchased all the assets of IntraFuse for an undisclosed sum. IntraFuse, a portfolio company of Surgical Frontiers, has developed advanced intramedullary implants
Irish medical technology company Medtronic has acquired US-based digital health technology company Klue for an undisclosed sum. Based in San Jose of California, Klue is involved in the
Hoya Group’s division Pentax Medical has secured CE mark for its Discovery artificial intelligence (AI) assisted polyp detector. The company has designed the AI polyp detector to help
SpeeDx announced the European launch of ResistancePlus MG FleXible, the first sample-to-answer test for detecting the sexually transmitted infection (STI) Mycoplasma genitalium (Mgen) and markers associated with azithromycin
Cardiovascular Systems (CSI), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced that the first patient in